Table 1.
Medication | Highest NDMA level, µg, per dose | Maximum daily dosing, mg | Cause of NDMA | FDA response |
---|---|---|---|---|
Ranitidine | 0.86 per 300 mg | 300 | Undetermined but increases with application of heat | Complete market withdrawal |
Nizatidine | 0.02 per 150 mg | 300 | Undetermined | Voluntary recalls of affected products |
Irbesartan | Unpublished | 300 | Manufacturing process | Voluntary recalls of affected products |
Losartan | Unpublished | 100 | Manufacturing process | Voluntary recalls of affected products |
Valsartan | 20.19 per 320 mg | 320 | Manufacturing process | Voluntary recalls of affected products |
Metformin a | 0.19 per 500 mg | 2000 | Undetermined | Voluntary recalls of affected products |
Comparison of NDMA levels of affected medications and cause of impurity as reported by the FDA as well as agency response. 4 , 6 , 8 Typical maximum daily dosing of oral products is reported.
Abbreviations: FDA, US Food and Drug Administration; NDMA, N‐nitrosodimethylamine.
Extended‐release formation.